Fidelis Capital Partners LLC Buys 1,669 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fidelis Capital Partners LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 30.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,169 shares of the healthcare conglomerate’s stock after purchasing an additional 1,669 shares during the period. UnitedHealth Group accounts for approximately 0.8% of Fidelis Capital Partners LLC’s portfolio, making the stock its 23rd biggest holding. Fidelis Capital Partners LLC’s holdings in UnitedHealth Group were worth $3,774,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Xponance Inc. increased its stake in shares of UnitedHealth Group by 4.2% in the fourth quarter. Xponance Inc. now owns 201,906 shares of the healthcare conglomerate’s stock worth $106,297,000 after purchasing an additional 8,226 shares during the period. Guardian Investment Management acquired a new stake in UnitedHealth Group during the fourth quarter worth about $1,911,000. Ninety One SA PTY Ltd grew its position in UnitedHealth Group by 16.1% during the fourth quarter. Ninety One SA PTY Ltd now owns 23,199 shares of the healthcare conglomerate’s stock worth $12,214,000 after buying an additional 3,217 shares in the last quarter. Oliver Lagore Vanvalin Investment Group grew its position in UnitedHealth Group by 12.6% during the fourth quarter. Oliver Lagore Vanvalin Investment Group now owns 214 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 24 shares in the last quarter. Finally, NBW Capital LLC grew its position in UnitedHealth Group by 3.1% during the fourth quarter. NBW Capital LLC now owns 10,858 shares of the healthcare conglomerate’s stock worth $5,716,000 after buying an additional 328 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Morgan Stanley decreased their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Barclays lifted their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Three equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $569.68.

UnitedHealth Group Trading Up 3.0 %

Shares of UnitedHealth Group stock traded up $14.17 on Thursday, hitting $493.16. 8,879,564 shares of the company’s stock traded hands, compared to its average volume of 4,525,576. The firm’s 50-day moving average price is $489.51 and its two-hundred day moving average price is $515.38. The stock has a market capitalization of $454.66 billion, a PE ratio of 30.38, a price-to-earnings-growth ratio of 1.28 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.26 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.75 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.